#VisualAbstract: Subcutaneous casirivimab and imdevimab reduced symptomatic COVID-19 infection among asymptomatic positive individuals
1. Close household contacts of SARS-CoV-2-infected individuals, who were asymptomatic and positive on RT-qPCR, had a significantly reduced risk of ...